References
- 1. Vonk AL, de Windt TS, Slaper-Cortenbach ICM, Saris DBF. Autologous, allogeneic, induced pluripotent stem cell or a combination stem cell therapy. Stem Cell Res Ther. 2015;6:94.10.1186/s13287-015-0086-1443090425976213
- 2. Kimbrel EA, Kouris NA, Yavanian GJ, et al. Mesenchymal stem cell population derived from human pluripotent stem cells displays potent immunomodulatory and therapeutic properties. Stem Cells Dev. 2014;23:1611-1624.10.1089/scd.2013.0554408636224650034
- 3. Isolex 300i Trening Manual, Version 2, Nexel Therapeutics Inc. USA, 2001, Section 2
- 4. McDonald-Hyman C, Turka LA, Blazar BR. Advances and challenges in immunotherapy for solid organ and hematopoietic stem cell transplantation. Sci Transl Med. 2015;7:280rv2.10.1126/scitranslmed.aaa6853442535425810312
- 5. Craig FE, Foon KA. Flow cytometric immunophenotyping for hematologic neoplasm. Blood. 2008;111:3941-3967.10.1182/blood-2007-11-12053518198345
- 6. Padmanee Sharma, James P. Allison, Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential. Cell Press. 2015;161:205-214.
- 7. Shabbir A, Cox A, Rodriguez-Menocal L, Salgado M, Van Badiavas E. Mesenchymal Stem Cell Exosomes Induce Proliferation and Migration of Normal and Chronic Wound Fibroblasts, and Enhance Angiogenesis In Vitro. Stem Cells Dev. 2015;24:1635-1647.10.1089/scd.2014.0316449979025867197
- 8. Bernardo ME, Fibbe WE. Mesenchymal stromal cells and hematopoietic stem cell transplantation, facilitate engraftment to treat steroid resistant acute graft-versus-host disease, Immunol Lett. 2015;168:215-221.
- 9. Cruz CR, Bollard CM. T-Cell and Natural Killer Cell Therapies For Hematologic Malignancies After Hematopoietic Stem Cell Transplantation: Enhancing The Graft-Versus-Leukemia Effect. Haematologica. 2015;100:709-719.10.3324/haematol.2014.113860445061626034113
- 10. De Becker A, Van Riet I. Mesenchymal Stromal Cell Therapy in Hematology: From Laboratory to Clinic and Back Again. Stem Cells Dev. 2015;24:1713-1729.10.1089/scd.2014.056425923433
- 11. Lendvai N, Cohen AD, Cho HJ. Beyond consolidation: auto-SCT and immunotherapy for plasma cell myeloma. Bone Marrow Transplant. 2015;50:770-780.10.1038/bmt.2015.525751647
- 12. Apperley J, Carreras E, Gluckman E, Gratwohl A, Massi T. The EBMT Handbook, 5th Edition: Haematopoietic Stem Cell Transplantation. Revised Edition; 2008.